Enforcement Mechanisms Available to the FDA

by | Apr 16, 2021 | Uncategorized

The mission of the Food and Drug Administration is to protect public health by ensuring compliance of products and goods with the Food, Drug, and Cosmetic Act. In order to do this, the FDA, through its centers, conducts post-market enforcement activities which include the removal of nonconforming products from the market and other actions to correct the violations. The type of enforcement activity is commensurate with the violations and may include a letter notifying the firm and requesting a correction to the criminal prosecution of the responsible firm or individual(s).

This whitepaper discusses the types of enforcement tools available to the FDA and what it means to the firm or the individual(s) involved.

Get the Enforcement Mechanisms Available to the FDA Whitepaper

Fill out the form below, and the webinar will get sent directly to your inbox.
Nikita Angane

Nikita Angane

Solutions Delivery Specialist - Ms. Angane is a Bioengineering graduate with experience in medical device commercialization, product development, quality system compliance and regulatory affairs. Her portfolio includes working on medical devices, combination products, and pharmaceuticals. As a Solutions Delivery Specialist at EMMA International, she offers her expertise to help our clients achieve an effective and sustainable quality system, and develop regulatory strategies for market access and compliance of new products in the US and international markets. Ms. Angane earned a Bachelor of Engineering in Biomedical Engineering from the University of Mumbai, India and an M.S. in Bioengineering from University of Illinois at Chicago.

More Resources

Pattern Recognition as a Quality Superpower

Pattern Recognition as a Quality Superpower

There are always new ways and reasons to apply pattern recognition to quality improvement. Better ensuring patient outcomes in health care facilities and improving accuracy for medical diagnoses are two such frontiers.
Record Control for a Regulated World

Record Control for a Regulated World

In a regulated industry, the prevailing posture of regulatory representatives, in my experience, has been “Show me proof.” In fact, the philosophy I’ve heard repeated by regulators is “If it wasn’t documented, it didn’t happen.”
EU MDR SSCP’s: The Importance of Readability

EU MDR SSCP’s: The Importance of Readability

Among many of the new requirements that EU MDR has introduced, the Summary of Safety and Clinical Performance (SSCP) is certainly one of the more confusing ones for many firms. SSCP’s are required for implantable and Class III devices under EU MDR and is intended to be a public document summarizing important safety and clinical performance information about the device.

Ready to learn more about working with us?

Pin It on Pinterest

Share This